Search

Author/Creator Wang, Jia-Yu

1. Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China. (15th September 2021)

Authors:
Han, Yi-Qun; Yi, Zong-Bi; Yu, Pei; Wang, Wen-Na; Ouyang, Qu-Chang; Yan, Min; Wang, Xiao-Jia; Hu, Xi-Chun; Jiang, Ze-Fei; Huang, Tao; Tong, Zhong-Sheng; Wang, Shu-Sen; Yin, Yong-Mei; Li, Hui; Yang, Run-Xiang; Yang, Hua-Wei; Teng, Yue-E.; Sun, Tao; Cai, Li; Li, Hong-Yuan
Other Names:
Qian Liren Academic Editor.
Journal:
Journal of oncology
Issue:
Volume 2021(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer. Issue 1 (December 2016)

Authors:
Chen, Xue-Lian; Du, Feng; Hong, Ruo-Xi; Wang, Jia-Yu; Luo, Yang; Li, Qing; Fan, Ying; Xu, Bing-He
Journal:
Chinese journal of cancer
Issue:
Volume 35:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗